Lupin Faces Decline In Second Quarterly Profit Levels By 41%
Lupin, the Indian pharmaceutical major registered a 41.5 per cent decline in its consolidated net profit at Rs 266 crore for the quarter ended September...
Tag : Lupin
Lupin Outlook for the Week (Oct 29, 2018 – Nov 02, 2018)
EquityPandit’s Outlook for Lupin for the week (Oct 29, 2018 – Nov 02, 2018) : LUPIN: Lupin closed the week on negative note losing around 2.90%....
Lupin Outlook for the Week (Oct 22, 2018 – Oct 26, 2018)
EquityPandit’s Outlook for Lupin for the week (Oct 22, 2018 – Oct 26, 2018) : LUPIN: Lupin closed the week on positive note gaining around 4.00%....
Lupin Outlook for the Week (Oct 15, 2018 – Oct 19, 2018)
EquityPandit’s Outlook for Lupin for the week (Oct 15, 2018 – Oct 19, 2018) : LUPIN: Lupin closed the week on positive note gaining around 0.80%....
Lupin Outlook for the Week (Oct 08, 2018 – Oct 12, 2018)
EquityPandit’s Outlook for Lupin for the week (Oct 08, 2018 – Oct 12, 2018) : LUPIN: Lupin closed the week on negative note losing around 6.90%....
Lupin Outlook for the Week (Oct 01, 2018 – Oct 05, 2018)
EquityPandit’s Outlook for Lupin for the week (Oct 01, 2018 – Oct 05, 2018) : LUPIN: Lupin closed the week on positive note gaining around 1.20%....
Lupin Outlook for the Week (Sep 24, 2018 – Sep 28, 2018)
EquityPandit’s Outlook for Lupin for the week (Sep 24, 2018 – Sep 28, 2018) : LUPIN: Lupin closed the week on negative note losing around 8.10%....
Lupin Outlook for the Week (Sep 17, 2018 – Sep 21, 2018)
EquityPandit’s Outlook for Lupin for the week (Sep 17, 2018 – Sep 21, 2018) : LUPIN: Lupin closed the week on positive note gaining around 1.00%....
Lupin Outlook for the Week (Sep 10, 2018 – Sep 14, 2018)
EquityPandit’s Outlook for Lupin for the week (Sep 10, 2018 – Sep 14, 2018) : LUPIN: Lupin closed the week on positive note gaining around 3.00%....
Lupin Receives Observation From U.S. FDA
The Indian Pharmaceutical leader, Lupin Limited today said in the BSE filing, that the U.S. Food and Drug Administration (FDA) has issued one observation after...